Although both HER2(3+) and HER2(2+)/FISH-positive subtypes belong to HER2-positive BC, the difference in cell surface HER2 protein level between the two subtypes has been suggested to affect their responses to NAT (15–19). This evidence concerns the gene BRD2 and breast cancer.